http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1337201-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee32d4a72d327e6b7ca4123d64ffd42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ed3bb06ffcaca70ed3478d2d9ff5ee8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-142 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B29D11-023 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B29D11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-14 |
| filingDate | 2001-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e4b0c54baa9627ffa4ed2b3e9a63d76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c7b133668869f1b94704e69901c987 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7498d775a95f95ef78d4f08d9666045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8c7facf1ca8b76b5f1a2fe910e64350 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7717ccb9dfb80a0319c3a4a9acc0d62f |
| publicationDate | 2005-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1337201-B1 |
| titleOfInvention | Keratoprothesis |
| abstract | The invention relates to a keratoprothesis (1), comprising a transparent optical center (2) and a marginal zone (3) surrounding said center. The keratoprothesis is configured as a flexible curved scleral lens from a flexible material and the marginal zone (3) is coated with a covalently bound, biocompatible coating to promote adherence of cell clusters. The marginal zone (3) at least partially consists of polyvinylidene fluoride (PVDF). The side of the transparent optical center (2) facing the eye (6) and/or facing away from it is coated with UV absorbers and/or the optical center (2) contains a UV absorber for preventing ultraviolet radiation from entering the eye (6) and for preventing the formation of radicals in the eye (6). The outer edge of the marginal zone (3), after implantation of the keratoprothesis (1), reaches far behind the zone of the ocular muscle attachments. The marginal zone (3), in the area of the ocular muscles (12), is fixated between the eyeball and the ocular muscles (12) in the range of the equator. The optical center (2) on the side of the marginal zone (3) facing the eye (6) is delimited by a peripheral implantation lip (5). The inventive keratoprothesis (1) allows for an excellent and permanent ingrowth without losing its good mechanical and optical properties. |
| priorityDate | 2000-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466 |
Total number of triples: 23.